MNE 5.26% 3.6¢ metallum limited

option comparisons, page-8

  1. 8,013 Posts.
    lightbulb Created with Sketch. 551
    Thanks to those who answered my initial query re the 2 option series ... some good points.

    I have bought some OBs with a plan to hold them until assays are announced, then, should the SP go up sell some of the OB holding and transfer profits across to the Os awaiting further developments in Q1 of next year which will have the effect of potentially giving me lerverage on leverage with the 2nd stage being free carried on entry.

    Of course if assays are rubbish then I will be stuck holding the OBs muttering to myself .... I wonder why I bought those.

    EB
 
watchlist Created with Sketch. Add MNE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.